Special Analysis: Addressing Key Concerns Around the FDA’s Final LDTs Rule
Experts answer key questions related to laboratory-developed test regulation during G2 Intelligence webinar.
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
Experts answer key questions related to laboratory-developed test regulation during G2 Intelligence webinar.
From - G2 Compliance Advisor
In 2016, the Australian government released medical billing records of 2.9 million people. They tried to protect patient privacy by…
From - Lab Compliance Advisor
Case: A new DOJ lawsuit accuses a West Virginia non-profit hospital and its business consultant of seeking to dominate the Ohio Valley market by…
From - Lab Compliance Advisor
Among the 10 new Work Plan items this month, three may have potential ramifications for at least some labs…
From - Lab Compliance Advisor
Fraudulent utilization and billing of urine drug screening first became a priority for federal enforcers since the…